R94.113 — Abnormal oculomotor study
Is R94.113 billable?
Yes — R94.113 is billable for FY2027. R94.113 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. R94.113 may be submitted for encounters from October 1, 2026 through September 30, 2027.
R94.113 at a glance
| Code | R94.113 |
|---|---|
| Description | Abnormal oculomotor study |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does R94.113 group to?
R94.113 sits in MDC 02 and helps define the logic of 2 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 124Other Disorders of the Eye with MCC or Thrombolytic Agentmedical
- 125Other Disorders of the Eye without MCCmedical
How is R94.113 listed in the Alphabetic Index?
These are the routes through the Alphabetic Index that lead to R94.113. They show the wording a clinician may have documented, which often differs from the Tabular description.
- Abnormal, abnormality, abnormalities › oculomotor study
Excludes1 — never code together — inherited from R90-R94
The conditions below can never be reported together with R94.113 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- abnormal findings on antenatal screening of mother (O28.-)
- diagnostic abnormal findings classified elsewhere - see Alphabetical Index
Excludes2 — not included here — inherited from Chapter 18
The conditions below are not part of R94.113, but a patient may have both at the same time. When documentation supports it, R94.113 and the excluded code may both be reported.
How long has R94.113 existed?
R94.113 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.